News from IVAC

January 2023

IVAC Collaborates with Global Partners to Tackle Cervical Cancer

Worldwide, cervical cancer is the fourth most common cancer among women, with an estimated 604,000 new cases and 342,000 cervical cancer-related deaths reported in 2020. Two types of HPV contribute to nearly 50% of high-grade cervical cancers, underscoring the need for continued prevention, screening, and education. Vaccination against HPV remains the primary prevention method globally; […]

Read More >
January 2023

IVAC’s Vaccine Hesitancy Training Course Has a Successful Test Run in Uttar Pradesh, India 

It is well-known that vaccines save lives, but their effectiveness continues to be undermined by rampant vaccine misinformation. Healthcare workers have voiced that they are not equipped with the right information or preparation to combat this often polarizing and sensitive topic. To address this need, IVAC researchers recently developed a training course aimed toward healthcare […]

Read More >
December 2022

VIRA Chatbot Competition Awarded to Three U.S. Health Departments

Health departments will use custom AI chatbots to address COVID-19 misinformation View original press release by NACCHO Washington, DC—The National Association of County and City Health Officials (NACCHO) has announced the first three winners of the VIRA X NACCHO competition. These selected health departments will receive a customized version of the Vaccine Information Resource Assistant […]

Read More >
November 2022

World Pneumonia Day 2022: Restoring Coverage of Pneumococcal Conjugate Vaccines as a Priority

The COVID-19 pandemic has led to major backsliding for childhood vaccinations with many of the world’s most vulnerable populations left not fully protected or not receiving any life-saving immunizations at all. Use of pneumococcal conjugate vaccines (PCV) is one of the most effective interventions for preventing pneumonia deaths among children under five and countries have […]

Read More >
September 2022

Webinar: Achieving the Sustainable Development Goals – Reaching the Communities Left Furthest Behind

Watch here: https://youtu.be/uVtHxJGHtJo Speakers: Dr. William Moss, International Vaccine Access Center Ms. Bujela Nokunceda, MP, Eswatini, Interparliamentary Union (IPU) Ms. Khalila Mbowe, Country Director, Girl Effect Tanzania Ms. Sonia Ancellin-Panzani, Head of Country Action, Scaling Up Nutrition (SUN) Ms. Anamaria Bejar, Director of Public Policy Engagement, Gavi, the Vaccine Alliance Summary The COVID-19 pandemic has […]

Read More >
August 2022

VIRA Partners to Launch a Competition and Chatbot

VIRA is a COVID-19 vaccine chatbot created by the Johns Hopkins International Vaccine Access Center and IBM to provide users with instant answers on vaccine questions 24/7. VIRA, which works in English and Spanish, understands users’ questions in natural language, and responds with facts and empathy. The VIRA project is excited to announce that it […]

Read More >